Microsoft PowerPoint - pp3 Amgen_Research[removed]2013_Final.ppt [Compatibility Mode] - PP3 - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-12-05 11:00:14 Sclerostin Myostatin Osteoprotegerin Stamulumab Denosumab Osteoporosis Cachexia Activin type 2 receptors Teriparatide Biology Osteopathies Amgen		Microsoft PowerPoint - pp3 Amgen_Research[removed]2013_Final.ppt [Compatibility Mode] Add to Reading List Source URL: www.nasa.gov Download Document from Source Website File Size: 2,38 MB Share Document on Facebook

	Info \| Médicament Votre médecin vous a prescrit un médicament contre l’ostéoporose : Tériparatide 20 µg (FORSTEO®) DocID: 1nFsd - View Document
	Il_Health and Living August v22.indd DocID: 1gz1v - View Document
	Can J App Sci 2012; 4(2): Yusra et al., 2012 Canadian Journal of Applied Sciences. 4(2): ; October, 2012 ISSN; Available online http://www.canajas.ca DocID: 1afdr - View Document
	Osteoporosis – pharmacological prevention and management in older people DocID: 18Smw - View Document
$Bone fractures / Osteopathies / Osteoporosis / Dual-energy X-ray absorptiometry / Bone density / Osteopenia / Strontium ranelate / Hip fracture / Teriparatide / Medicine / Health / Drugs$	professional Darren Parker An audit of osteoporotic patients in an Australian DocID: 17Xjg - View Document